Brief: Nuformix Says NXP002 Formulations For Nebulisation Can Be Efficiently Delivered To Lung

Nuformix

27/06/2022 07:37

June 27 (Reuters) - Nuformix PLC  NFXN.L :
    * NUFORMIX PLC - NXP002 CAN BE FORMULATED IN A SIMPLE AND
STABLE
SOLUTION SUITABLE FOR INHALED DELIVERY VIA NEBULISATIOM
    * NUFORMIX PLC - NXP002 FORMULATIONS FOR NEBULISATION CAN BE
EFFICIENTLY DELIVERED TO LUNG
    * NUFORMIX- NXP002 CAN DOSE-DEPENDENTLY REGULATE PRODUCTION
OF
MEDIATORS RELEVANT TO LUNG FIBROSIS AND INFLAMMATION FOLLOWING
LPS CHALLENGE

Source text for Eikon:  ID:nRSa2044Qa 
Further company coverage:  NFXN.L 

 ((Reuters.Briefs@thomsonreuters.com;))